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Abstract  
Cluster analysis of a comprehensive clinical-anamnestic and paraclinical examination 
with the phenotype of exercise-induced bronchial asthma in schoolchildren depending on the 
type of acetylation. Heterogeneity of this cohort of patients has been found which requires a 
differential approach to administration of therapeutic measures. 
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Introduction. Recognition of heterogeneity of bronchial asthma (BA) with different 
degree of severity of bronchial obstruction, frequency of exacerbations and various response 
to treatment induce more comprehensive study of BA phenotypes [1, 4]. In contemporary 
studies physiological, morphological and molecular-genetic mechanisms involved in 
pathogenesis of BA have been investigated, clinical phenotypes of its course have been 
determined, enabling clinicians to apply individualized approach to therapy [8]. During the 
recent years cluster analysis has been used to isolate phenotypes of BA [7]. 
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Exercise-induced bronchial asthma (EIBA) is not a homogeneous phenotype of the 
disease, and the mechanism of its formation remains unclear. Increased scientific interest to 
the problem of exercise – induced bronchial asthma is connected with the formation of a 
convenient model to study reverse bronchial spasm and refractoriness of patients to physical 
exertion, especially in children with evidenced psycho-emotional stress factor under 
conditions of limited motor activity [5]. 
As acetylation rate is considered to be one of the genetic markers of metabolic 
processes, scientific studies investigate possibilities of estimation of BA risks on the basis of 
detection of the type of acetylation of patients [9]. The use of cluster analysis for diversion of 
clinical phenotype of BA is the most objective and enables to avoid many systematic and/or 
subjective mistakes [2,10,13], and it is rather promising concerning the aspect of its 
application to optimize individualized treatment. 
Objective: to analyze clinical-paraclinical peculiarities of EIBA in schoolchildren 
depending on their acetylation status by means of making cluster analysis to study the tactics 
of an individualized treatment.   
Materials and methods. Keeping to the principles of bioethics 23 children suffering 
from EIBA were examined on the basis of Regional Children Clinical Hospital (the town of 
Chenivtsi). The disease was diagnosed in case after spirography test with dosed physical 
exercise bronchial spasm index was higher than 15% [5]. The diagnosis and severity of the 
course were verified on the basis of current national and international [11] regulating 
documents. An average age of the children examined was 12,2±0,6 years. Boys (65,2%) and 
rural residents (56,5%) prevailed. 
Phenotype peculiarities were studied discretely in the groups of children formed 
depending on acetylation status [6] with the use of cluster analysis. The components of a 
comprehensive examination were considered to be forming signs of cluster analysis in the 
groups of patients with EIBA, in particular: clinical-anamnestic characteristics (topical body 
mass index, severity of the first day of exacerbation, genealogical index by atopic diseases), 
indicators of efficacy of the basic treatment by ACT-test, markers of inflammatory process in 
the bronchi (the content of nitrogen monoxide metabolites and general protein in the expired 
air condensate, a relative content of eosinophil and neutrophil granulocytes in induced 
sputum), indicators of atopic reactivity (the content of general IgE and ІL-4 in the blood and 
results of skin allergy tests with non-bacterial allergens), and non-specific hyperactivity of the 
bronchi (according to the values of bronchial lability index, provocative concentration, 
histamine dose and dose-depending curve). 
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Among patients with EIBA the I clinical group included 10 children with quick 
acetylation mechanisms, an average age of 11,6±0,9 years, prevailing number of boys 
(80,0%), and urban residents (50,5%). The II clinical group included 13 patients with EIBA 
and slow acetylation status, an average age of schoolchildren12,6±0,8 years, prevailing 
number of boys (53,8%), rural residents constituted 61,5%. 
Cluster analysis of the results of examination of a cohort of patients with EIBA was 
conducted. The probability approach by means of K-means method was used according to 
which every analyzed object referred to one of k classes [12]. 
Results of the study and their discussion. On the basis of the cluster analysis results 
of clinical-paraclinical signs of the examined children suffering from EIBA with quick 
acetylation status a number of features were determined. Their consideration enabled to 
differentiate three cluster groups (Table 1).   
Table 1 
Cluster subgroups of children with exercise-induced bronchial asthma and quick 
acetylation status (M±m) 
Clinical-paraclinical characteristics Cluster 1 Cluster 2 Cluster 3 Р 
Body mass index (kg/m2) 21,4±2,7 18,6±3,5 17,4±2,0 ND 
Genetic index by atopic diseases, 
standard units 0,18±0,16 0,13±0,06 0,20±0,02 
ND 
АСТ-test before initiation of basic 
therapy, points 14,9±0,6 15,4±3,5 15,9±0,9 
ND 
Severity of the 1st day of attack, 
points 9,7±7,5 18,6±3,5 17,2±5,0 
ND 
Eosinophils in induced sputum, % 12,7±8,8 4,3±3,2 5,3±3,0 ND 
Neutrophils in induced sputum, % 53,7±26,9 53,4±7,5 42,4±23,5 ND 
Content of nitrogen monoxide 
metabolites in expired air condensate, 
mcmol/L 
51,8±3,9 44,8±6,8 48,8±1,1 
ND 
Content of total protein in expired air 
condensate, mcmol/L 3,4±0,1 3,4±0,1 3,4±0,1 
ND 
Bronchial spasm index, % 24,9±13,6 24,4±6,4 23,4±10,9 ND 
Bronchial dilation index, % 5,6±7,0 27,2±22,1 17,8±12,9 ND 
Bronchial lability indicator, % 30,6±12,7 51,7±18,6 29,2±21,1 ND 
Threshold histamine concentration, 
mg/ml 1,00±0,9 0,44±0,26 0,36±0,31 
ND 
Threshold histamine dose, mg 0,21±0,20 0,08±0,06 0,07±0,06 ND 
Dose-depending curve, standard units 2,13±0,90 1,59±0,53 1,90±0,1 ND 
Content of total ІgE in the blood, 
IU/ml 802,2±144,9 1364,1±73,4 151,3±49,0 
ND 
Content of interleukin-4 in the blood, 
pg/ml 19,1±11,6 12,8±4,7 12,7±4,5 
ND 
Note. ND – no distinction 
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On the basis of cluster analysis we have found that the I subgroup included patients 
suffering from EIBA prone to excessive body mass characterized by insufficient control of 
the course of the disease, probably at the expense of marked inflammation of the respiratory 
tract of eosinophilic character. 
The ІІ cluster subgroup included patients with quick acetylation mechanisms and 
susceptibility to atopic reactivity, whose course of the disease differed by severe exacerbation 
and insufficient control against the ground of basic therapy. It might be caused by pronounced 
bronchial lability bot in response of dosed physical exertion and inhalation of a short-term 
selective adrenergic agonist. 
The ІІІ cluster subgroup included “quick acetylators” with EIB, severe exacerbations 
and insufficient control of which was explained by severe hypersensitivity of the bronchi to 
histamine and their expressed hyper-reactivity. 
The discrete analysis of the II clinical group of children managed to determine its 
phenotype heterogeneity and isolate three cluster subgroups (Table 2). 
On the basis of the data obtained the I cluster subgroup was found to include patients 
with EIBA with a slow acetylation status, susceptibility to excessive body weight and ІgE-
dependent reactions in the body, during whose examination a considerable bronchial lability 
was found. 
The ІІ cluster subgroup included patients with EIBA with a slow acetylation 
mechanisms characterized by severe exacerbations and insufficient control of the diseases at 
the expense of severe hyper-sensitivity of the respiratory tract to histamine and their 
expressed lability. 
On the contrary, representatives of the III subgroup are prone to severe exacerbations 
and insufficient control at the expense of inflammatory components mainly. At the same time, 
relatively less indices of non-specific reactivity of the bronchi in those children can be 
explained by a formed rigidity of the bronchial wall.   
Therefore, on the basis of the conducted cluster analysis of clinical-paraclinical indices 
considering the character of acetylation among schoolchildren with EIBA the subgroups of 
children with different control of symptoms of the disease and severity of attacks were 
detected, enabling to individualize both basic anti-inflammatory therapy and relieve 
desobstructive treatment of the attack. 
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Table 2 
Cluster subgroups of children with exercise-induced bronchial asthma and slow 
acetylation status (M±m) 
Clinical-paraclinical characteristics  Cluster 1 
 
Cluster 2 
 
Cluster 3 
 
Р 
Body mass index (kg/m2) 23,5±5,4 18,7±2,6 22,0±1,5 ND 
Genetic index by atopic diseases, 
standard units  0,16±0,07 0,17±0,08 0,19±0,05 
ND 
АСТ-test before initiation of basic 
therapy, points  15,6±2,9 14,6±1,3 13,4±2,1 
ND 
Severity of the 1st day of attack, 
points  12,2±4,5 16,0±4,9 18,1±2,4 
ND 
Eosinophils in induced sputum, % 9,0±7,5 9,2±1,5 5,5±4,8 ND 
Neutrophils in induced sputum, % 51,1±12,9 54,8±6,8 41,0±16,4 ND 
Content of nitrogen monoxide 
metabolites in expired air 
condensate, mcmol/L  
43,9±17,8 42,3±1,6 43,1±0,2 
ND 
Content of total protein in expired 
air condensate, mcmol/L  3,5±0,4 3,6±0,2 4,3±0,8 
ND 
Bronchial spasm index, % 34,3±13,2 26,2±12,6 18,0±2,8 ND 
Bronchial dilation index, % 30,6±19,2 22,3±12,2 4,3±5,7 ND 
Bronchial lability indicator, % 65,0±9,7 48,6±22,4 22,3±8,5 ND 
Threshold histamine concentration, 
mg/ml  0,58±0,07 0,16±0,02 0,42±0,32 
ND 
Threshold histamine dose, mg  0,12±0,03 0,03±0,01 0,09±0,06 ND 
Dose-depending curve, standard 
units  2,1±0,3 2,1±0,5 2,2±0,1 
ND 
Content of total ІgE in the blood, 
IU/ml  1166,4±159,3 715,6±148,1 120,1±89,6 
ND 
Content of interleukin-4 in the 
blood, pg/ml  9,3±7,1 9,0±2,5 12,5±4,4 
ND 
Note. ND – no distinction 
 
Conclusions  
1. The results of cluster analysis of a comprehensive clinical-anamnestic and 
paraclinical examination of schoolchildren with the phenotype of exercise-induced bronchial 
asthma demonstrated their heterogeneity associated with the character if acetylation 
processes, that should be considered while making the plan of basic anti-inflammatory 
treatment and during treatment of attacks of the disease.    
2. The patients with quick type of acetylation with excessive body weight of 
eosinophilic character in the bronchi present insufficient efficacy of basic therapy which 
substantiate their implementation according to the “step upwards” recommendations at the 
expense of an increased dose of inhalation glucocorticosteroid. In “quick acetylators” with 
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susceptibility to atopic reactivity and severe exacerbations the treatment of attacks should 
include liberal administration of systemic glucocorticosteroids. In the basic therapy of “quick 
acetylators” whose severe exacerbations and insufficient control are explained by severe 
hyper-sensitivity of the bronchi to histamine and their marked hyper-reactivity “de-
escalation” principle is reasonable to be indicated. 
3. Patients with exercise-induced bronchial asthma with a slow acetylation status, 
prone to excessive body weight, ІgE-dependent reaction and severe exacerbations with 
insufficient control, probably at the expense of neutrophil character of inflammation in the 
bronchi, in addition to inhalation glucocorticosteroids prolonged theophyllines should be 
indicated. 
Prospects of further studies: to continue to study phenotype heterogeneity of 
bronchial asthma in children and determine the tactics of a controlled therapy. 
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